BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 35219245)

  • 1. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
    Cantini L; Mentrasti G; Russo GL; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; Fancelli S; Caliman E; Della Gravara L; Malapelle U; Filetti M; Piras M; Toscano G; Zullo L; De Tursi M; Di Marino P; D'Emilio V; Cona MS; Guida A; Caglio A; Salerno F; Spinelli G; Bennati C; Morgillo F; Russo A; Dellepiane C; Vallini I; Sforza V; Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri V; Emili R; Roca E; Migliore A; Galassi T; Rocchi MLB; Berardi R
    ESMO Open; 2022 Apr; 7(2):100406. PubMed ID: 35219245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer recovery focus post pandemic: an income-deprived area paradigm.
    Jaitly J; Mavilakandy A; Naeem M; Reddy RV; Goodman L; Johnson N; Frost M; Tsaknis G
    Clin Med (Lond); 2023 Jan; 23(1):38-44. PubMed ID: 36697004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying reasons for post-mortem diagnosed lung cancer cases - A robust retrospective comparative study from Hungary (HULC study).
    Kiss ZN; Bogos K; Tamási L; Ostoros G; Müller V; Bittner N; Sárosi V; Vastag A; Knollmajer K; Várnai M; Kovács K; Berta A; Köveskuti I; Karamousouli E; Rokszin G; Abonyi-Tóth Z; Barcza Z; Kenessey I; Weber A; Nagy P; Freyler-Fadgyas P; Szócska M; Szegner P; Hilbert L; Géczy GB; Surján G; Moldvay J; Vokó Z; Gálffy G; Polányi Z
    Front Oncol; 2022; 12():1032366. PubMed ID: 36505881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic delay in bronchiectasis: an Italian perspective.
    Chessari C; Simonetta E; Amati F; Nigro M; Stainer A; Sotgiu G; Puci M; Gramegna A; Blasi F; Morlacchi LC; Buscemi AAMD; Conio V; Sanci V; Corsico AG; Faverio P; Michalak W; Luppi F; Crimi C; Vancheri C; Campisi R; Vulpi MR; Carpagnano GE; Cicchetti M; Sekretna K; Scichilone N; Battaglia S; Aliberti S
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38500794
    [No Abstract]   [Full Text] [Related]  

  • 5. The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach.
    Tsiligianni I; Christodoulakis A; Monastirioti A; Mavroudis D; Agelaki S
    NPJ Prim Care Respir Med; 2024 Apr; 34(1):5. PubMed ID: 38684681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
    Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
    Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High remnant cholesterol as a risk factor for developing chronic kidney disease in patients with prediabetes and type 2 diabetes: a cross-sectional study of a US population.
    Zhu W; Liu Q; Liu F; Jiao C; Zhang L; Xie H
    Acta Diabetol; 2024 Mar; ():. PubMed ID: 38436703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in staging, treatment, and mortality in non-small cell lung cancer.
    Duncan FC; Al Nasrallah N; Nephew L; Han Y; Killion A; Liu H; Al-Hader A; Sears CR
    Transl Lung Cancer Res; 2024 Jan; 13(1):76-94. PubMed ID: 38405005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Outcomes of COVID-19 Pandemic on Non-Small Cell Lung Cancer Screening and Management.
    Orelaru F; Edwards M; Raleigh R; Abunayla A; Bush R; Porter S; Schumaker K; Albright J; Adams KN
    Surg J (N Y); 2023 Oct; 9(4):e156-e161. PubMed ID: 38197091
    [No Abstract]   [Full Text] [Related]  

  • 10. A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).
    Molinier O; Guguen C; Marcq M; Chene AL; Masson P; Bigot F; Denis F; Empereur F; Saulnier P; Urban T
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and lung cancer.
    Melocchi L; Mengoli MC; Bogina G; Facchetti M; Migliorati F; Gandolfi L; Rossi G
    Pathologica; 2023 Oct; 115(5):284-291. PubMed ID: 38054903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease 2019 and lung cancer: where are we?
    Ocanto A; Mielgo-Rubio X; Luna Tirado J; Linares Mesa N; López Valcárcel M; Pedraza S; Barragan VV; Nieto PV; Martín JZ; Couñago F
    Explor Target Antitumor Ther; 2023; 4(5):1082-1094. PubMed ID: 38023992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resource allocation during the coronavirus disease 2019 pandemic and the impact on patients with lung cancer: a systematic review.
    El-Andari R; Fialka NM; Jogiat U; Laing B; Bédard ELR; Nagendran J
    Interdiscip Cardiovasc Thorac Surg; 2023 Dec; 37(6):. PubMed ID: 38015831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors.
    Ariyasu R; Kakuto S; Miyadera K; Akita T; Kiritani A; Tsugitomi R; Amino Y; Uchibori K; Kitazono S; Yanagitani N; Nishio M
    JTO Clin Res Rep; 2023 Jun; 4(6):100524. PubMed ID: 37426307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Perioperative Outcomes after Robotic-Assisted Pulmonary Lobectomy during the COVID-19 Era.
    Doyle WN; Nguyen D; West WJ; Fiedler CR; Labib KM; Ladehoff L; Dumitriu Carcoana AO; Marek JC; Malavet JA; Moodie CC; Garrett JR; Tew JR; Baldonado JJAR; Fontaine JP; Toloza EM
    Surg Pract Sci; 2023 Jun; 13():100172. PubMed ID: 37139165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
    Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.
    Cona MS; Riva A; Dalu D; Gabrieli A; Fasola C; Lipari G; Pozza G; Rulli E; Galli F; Ruggieri L; Masedu E; Parma G; Chizzoniti D; Gambaro A; Ferrario S; Antista M; De Monte M; Tarkowski MS; La Verde N
    Cancer Med; 2023 Jun; 12(12):12967-12974. PubMed ID: 37114577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization.
    Akbari A; Nazari-Khanamiri F; Ahmadi M; Shoaran M; Rezaie J
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.
    Wang L; Wang Y; Cheng X; Li X; Li J
    Transl Oncol; 2023 Feb; 28():101605. PubMed ID: 36568513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 pneumonia: lessons learned, challenges, and preparing for the future.
    Ufuk F; Savaş R
    Diagn Interv Radiol; 2022 Nov; 28(6):576-585. PubMed ID: 36550758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.